# Wixela Inhub

NDC: 0378-9322
Generic name: fluticasone propionate and salmeterol
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER
Routes: RESPIRATORY (INHALATION)
Marketing started: 20190211

FDA application: ANDA208891

## Active ingredients

- FLUTICASONE PROPIONATE: 500 ug/1
- SALMETEROL XINAFOATE: 50 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-9322"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-9322
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3beef422-8a07-4a45-9ba6-414511e4b7e2